A polymorphic microsatellite that mediates induction of PIG3 by p53

被引:197
作者
Contente, A
Dittmer, A
Koch, MC
Roth, J
Dobbelstein, M [1 ]
机构
[1] Univ Marburg Klinikum, Inst Virol, Marburg, Germany
[2] Univ Marburg Klinikum, Inst Humangenet, Marburg, Germany
[3] Univ Marburg Klinikum, Abt Gastroenterol & Stoffwechsel, Marburg, Germany
关键词
D O I
10.1038/ng836
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The gene PIG3 is induced by the tumor suppressor p53 but not by p53 mutants unable to induce apoptosis, suggesting its involvement in p53-mediated cell death(1-3). Here we show that p53 directly binds and activates the PIG3 promoter, but not through the previously described DNA element(1). Instead, p53 interacts with a pentanucleotide microsatellite sequence within the PIG3 promoter (TGYCC)(n) where Y= C or T. Despite its limited similarity to the p53-binding consensus(4,5), this sequence is necessary and sufficient for transcriptional activation of the PIG3 promoter by p53 and binds specifically to p53 in vitro and in vivo. In a population of 117 healthy donors from Germany, the microsatellite was found to be polymorphic, the number of pentanucleotide repeats being 10, 15, 16 or 17, and the frequency of alleles 5.1%, 62.0%, 21.4% and 11.5%, respectively. The number of repeats directly correlated with the extent of transcriptional activation by p53. This is the first time that a microsatellite has been shown to mediate the induction of a promoter through direct interaction with a transcription factor. Moreover, this sequence of PIG3 is the first p53-responsive element found to be polymorphic. Inheritance of this microsatellite may affect an individual's susceptibility to cancer.
引用
收藏
页码:315 / 320
页数:6
相关论文
共 22 条
  • [1] Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations
    Brachmann, RK
    Yu, KX
    Eby, Y
    Pavletich, NP
    Boeke, JD
    [J]. EMBO JOURNAL, 1998, 17 (07) : 1847 - 1859
  • [2] Evolution of simple repeats in DNA and their relation to human disease
    Djian, P
    [J]. CELL, 1998, 94 (02) : 155 - 160
  • [3] A TRANSCRIPTIONALLY ACTIVE DNA-BINDING SITE FOR HUMAN P53 PROTEIN COMPLEXES
    FUNK, WD
    PAK, DT
    KARAS, RH
    WRIGHT, WE
    SHAY, JW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (06) : 2866 - 2871
  • [4] A simplified system for generating recombinant adenoviruses
    He, TC
    Zhou, SB
    da Costa, LT
    Yu, J
    Kinzler, KW
    Vogelstein, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) : 2509 - 2514
  • [5] REGULATION OF THE SPECIFIC DNA-BINDING FUNCTION OF P53
    HUPP, TR
    MEEK, DW
    MIDGLEY, CA
    LANE, DP
    [J]. CELL, 1992, 71 (05) : 875 - 886
  • [6] Koch P, 2001, CANCER RES, V61, P5941
  • [7] p53, the cellular gatekeeper for growth and division
    Levine, AJ
    [J]. CELL, 1997, 88 (03) : 323 - 331
  • [8] SEVERAL HYDROPHOBIC AMINO-ACIDS IN THE P53 AMINO-TERMINAL DOMAIN ARE REQUIRED FOR TRANSCRIPTIONAL ACTIVATION, BINDING TO MDM-2 AND THE ADENOVIRUS-5 E1B 55-KD PROTEIN
    LIN, JY
    CHEN, JD
    ELENBAAS, B
    LEVINE, AJ
    [J]. GENES & DEVELOPMENT, 1994, 8 (10) : 1235 - 1246
  • [9] p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
    Müller, M
    Wilder, S
    Bannasch, D
    Israeli, D
    Lehlbach, K
    Li-Weber, M
    Friedman, SL
    Galle, PR
    Stremmel, W
    Oren, M
    Krammer, PH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) : 2033 - 2045
  • [10] A model for p53-induced apoptosis
    Polyak, K
    Xia, Y
    Zweier, JL
    Kinzler, KW
    Vogelstein, B
    [J]. NATURE, 1997, 389 (6648) : 300 - 305